Expert Review of Anti-Infective Therapy

Article	Citations
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	108
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	91
Visceral leishmaniasis elimination in India: progress and the road ahead	70
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	64
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	51
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	48
Challenges in preserving antibiotic effectiveness: time for a novel approach	43
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	41
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	40
Neonatal ocular prophylaxis in the United States: is it still necessary?	40
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	39
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	30
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	29
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	27
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	27
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	26
Treatment of vaginitis caused by non-albicans Candida species	26
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	25
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	24
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	24
Reemergence of monkeypox: prevention and management	23
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	23

Identifying predictors of treatment failure with community-acquired pneumonia: an update	23
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	23
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective	22
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	22
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	21
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	21
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections	19
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	18
Infliximab as a potential treatment for COVID-19	18
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	18
Diagnostic and management strategies for chronic hepatitis E infection	17
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	17
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	17
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	17
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta	17
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	17
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges	16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	16
Correction	16
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies	16
Risk of HIV viral rebound after SARS-CoV-2 infection among people living with HIV on antiretroviral therapy: a retrospective matched cohort study	15
Statement of Retraction	15
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	15
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	15
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	15
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	15
The serological dilemma: rethinking syphilis treatment evaluation	14
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	14
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	14
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	14
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	14
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	14
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	13
Diagnosing fungal infections in clinical practice: a narrative review	13
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	12
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	12
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	12
The evolving debate around screening for Chlamydia trachomatis	12
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	12
Monoclonal antibodies for the treatment of COVID-19 infection in children	12
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	12
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	11
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	11
Challenges associated with pertussis detection, monitoring, and vaccination in adults	11
How can we tackle the overuse of antibiotics in low- and middle-income countries?	11
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	11
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	11
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	10
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	10
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	10

How do we best manage Clostridioides difficle infections in the elderly?	10
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	10
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	10
A 96-week efficacy and safety of BIC/FTC/TAF in ART-naïve HIV-1 infected patients in China	10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	10
Tocilizumab for the treatment of COVID-19	10
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	9
Now that griseofulvin is not available, what to do with tinea capitis treatments?	9
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	9
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance	9
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	9
Gram-positive infections in special populations. Expert view on the role of dalbavancin	9
New insights into the treatment of acute otitis media	9
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	9
Artificial intelligence and prescription of antibiotic therapy: present and future	9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	9
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	8
Containment strategies for COVID-19 in India: lessons from the second wave	8
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	8
Past, present, and future perspectives on aztreonam and avibactam	8
Global importance of new treatment strategies to efforts to control hepatitis B virus	8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	8
An update on newer antifungals	8
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	8
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review	7
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	7
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	7
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	7
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	7
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	7
Host defense mechanisms against Candida auris	7
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	7
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta	7
An update on antimicrobial selection and duration for intra-abdominal infections	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	7
Brucellosis control methods with an emphasis on vaccination: a systematic review	6
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	6
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	6
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	6
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	6
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	6
Can probiotics replace antibiotics? Not yet, says the evidence	6
Brincidofovir in the Era of Mpox	6
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	6
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	6
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	6
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	6
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	6
Non-cancerous complications in HTLV-1 carriers	6
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	6
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	6
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	6
How do we change our approach to COVID with the changing face of disease?	6
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	6
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	5
Langya henipavirus outbreak	5
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	5
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	5
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	5
Letter to the Editor: the earliest observation of bla NDM was in Israel	5
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	5
HIV postnatal prophylaxis: how long is long enough?	5
From guesswork to guidelines: advancing diagnostic stewardship in immunocompromised hosts	5
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	5
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	5
Genomic surveillance of Neisseria gonorrhoeae : a crucial tool in the global fight against antimicrobial resistance	5
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	5
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	5
False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews	5

HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	5
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	5
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	5
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	5
Omadacycline in treating community-based infections: a review and expert perspective	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	5
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	5
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	5
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	5
Letter to the editor: “real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients”	5
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	5
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis	5
Artificial intelligence and its application in clinical microbiology	5
Candida auris biofilm: a review on model to mechanism conservation	5
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	4
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	4
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	4
Managing sepsis in the era of precision medicine: challenges and opportunities	4
Personalized care approaches to hepatitis C therapy: recent advances and future directions	4
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	4
Therapeutic strategies to address monkeypox	4
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	4
Biosimilars as antivirals: opportunities and challenges	4
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	4
The antifungal pipeline for invasive fungal diseases: what does the future hold?	4
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	4
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	4
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	4
Sepsis management in the antimicrobial resistance era	4
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	4
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	4
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	4
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	4
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	4
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	4
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	4
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective	4
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	4
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4
Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients	3
C5 inhibitors are not C5a inhibitors	3
Is self-medication with antibiotics among the public a global concern: a mixed-methods systematic review	3
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance	3
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies	3
Evaluation of Tamarix nilotica Fractions in Combating Candida albicans Infections	3
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	3
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences	3
Updates in the clinical management of tuberculous meningitis	3
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	3
Ceftobiprole medocaril for the treatment of pneumonia	3
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment	3
‘Real-life’ approach to applying PK/PD principles in infectious diseases clinical practice without access to prompt TDM	3
Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders	3
An interview with Laura Piddock - by Felicity Poole, commissioning editor	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis	3
Challenges and controversies of urinary tract infection treatment in kidney transplant recipients	3
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	3
Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development po	3
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	3
Doxycycline post-exposure prophylaxis as prevention of STIs – the golden bullet?	3
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	3
Penile microbiomes have important implications for HIV susceptibility and broader reproductive health	3
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	3
Anti-leishmanial therapies: overcoming current challenges with emerging therapies	3
An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis	3
Interventions to improve outcomes in community-acquired pneumonia	3
Addressing late HIV presentation: the current knowledge and unmet needs	3
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	3
The impact of COVID-19 on the HIV continuum of care: challenges, innovations, and opportunities	3
Gender trend of monkeypox virus infection	3
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications	3
A four-drug combination oral tablet of darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for the treatment of HIV-1 infection in adults	3
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	3
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	3
Visited India? Metronidazole may not cure your Giardia infection	3
From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections	3
Fighting with brain-eating amoeba: challenges and new insights to open a road for the treatment of Naegleria fowleri infection	3
Impact of tuberculosis disease on human gut microbiota: a systematic review	3